IRF5-IN-1
IRF5-IN-1 (Compound C5) is a conformationally locked inhibitor for SLC15A4. IRF5-IN-1 blocks the downstream IRF5 activation, inhibits the TLR7/8 signaling pathway. IRF5-IN-1 exhibits anti-inflammatory responses[1].
Product Specifications
CAS Number
[689270-18-6]
UNSPSC
12352005
Hazard Statement
H315-H319-H335
Target
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/irf5-in-1.html
Purity
99.91
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C(NCCCN1CCCCC1C)C2=CC(C3=CC=C(OCC)C=C3)=NC4=CC=CC=C42
Molecular Formula
C27H33N3O2
Molecular Weight
431.57
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human BTLA shRNA (UAS) - Lentiviral human BTLA shRNA (UAS, RFP) (100)
